To Evaluate the Safety in Patients Taking Duloxetine for Stress Urinary Incontinence

Completed · Phase 3

Conditions studied: Stress Urinary Incontinence

In brief

This is an on-going study to evaluate the long-term safety and maintenance of effect of duloxetine in patients suffering with stress urinary incontinence.

Key facts

Study ID

NCT00190632

Run by

Eli Lilly and Company

People needed

600

Starts

2001-03-01

Expected to finish

2006-04-01

Last updated by the study team

2007-01-26

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Have had symptoms of SUI for at least 3 months prior to study entry.
• Have urine leakage most often associated with activity (such as coughing, sneezing, exercise).
• Ambulatory and able to use a toilet independently and without difficulty.

You may not qualify if…

• Subjects who participated or were discontinued from any previous studies investigating duloxetine.
• Use of excluded medications within 14 days prior to study entry or at any time during the study.
• Subjects who currently have or have had a history of urogenital cancer.

Where it is running

• For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST) or speak with your personal physician — Cleveland, Ohio, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.